HTG Molecular Diagnostics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
TUCSON, Ariz., Jan. 27, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10, 2016 in New York.